High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.
- DOI
- 10.1016/j.cllc.2026.04.010
- Published
- 2026 Jun
- Container
- Clinical lung cancer
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.cllc.2026.04.010,
title = {High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.},
author = {Nie Y and Staley A and Hinz TK and Perez-Johnston R and Merrick DT and Yang MC and Davies KD and Bunn PA and Aisner DL and Camidge DR and Schenk EL and Heasley LE and Patil T},
year = {2026},
journal = {Clinical lung cancer},
doi = {10.1016/j.cllc.2026.04.010},
url = {https://doi.org/10.1016/j.cllc.2026.04.010}
}RIS
TY - JOUR TI - High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors. AU - Nie Y AU - Staley A AU - Hinz TK AU - Perez-Johnston R AU - Merrick DT AU - Yang MC AU - Davies KD AU - Bunn PA AU - Aisner DL AU - Camidge DR AU - Schenk EL AU - Heasley LE AU - Patil T PY - 2026 JO - Clinical lung cancer DO - 10.1016/j.cllc.2026.04.010 UR - https://doi.org/10.1016/j.cllc.2026.04.010 ER -
APA
Y, N., A, S., TK, H., R, P., DT, M., MC, Y., KD, D., PA, B., DL, A., DR, C., EL, S., LE, H., & T, P. (2026). High Programmed Death-Ligand 1 Expression is Associated With a Shorter Progression Free Survival in ALK-Rearranged Lung Cancer Patients Treated With First Line Tyrosine Kinase Inhibitors.. Clinical lung cancer. https://doi.org/10.1016/j.cllc.2026.04.010
Source records
- pubmed · retrieved 2026-09-26T22:06:33.361Z